Receptors for proteins modified by advanced glycation endproducts (AGE) - Their functional role in atherosclerosis

Mechanisms of Ageing and Development

Volumn 107, Issue 3, 1999, Pages 333-346

  Sano, Hiroyuki ^a   Nagai, Ryoji ^a   Matsumoto, Kenshi ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGE); AGE receptor; Atherosclerosis; Macrophage scavenger receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GALECTIN 3; GLUCOSE; MONOCLONAL ANTIBODY; PROTEIN; RECEPTOR; SCAVENGER RECEPTOR; SCHIFF BASE;

AGING; ATHEROSCLEROSIS; CONFERENCE PAPER; ENDOCYTOSIS; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; CHO CELLS; CRICETINAE; ENDOCYTOSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MACROPHAGES; MICE; PROTEINS; RABBITS; RECEPTORS, CELL SURFACE;

ORYCTOLAGUS CUNICULUS;

EID: 0033559086     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(99)00011-1     Document Type: Conference Paper

References (58)

1. Acton, S.L., Scherer, P.E., Lodish, H.F., Krieger, M., 1994. Expression cloning of SR-BI, a CD36-related Class B scavenger receptor. J. Biol. Chem. 269, 21 003-21 009.
2. Adachi, H., Tsujimoto, M., Arai, H., Inoue, K., 1997. Expression cloning of a novel scavenger receptor from human endothelial cells. J. Biol. Chem. 272, 31 217-31 220.
3. Araki, N., Higashi, T., Mori, T., et al., 1995. Macrophage scavenger receptor mediates the endocytic uptake of advanced glycation end-products of the Maillard reaction. Eur. J. Biochem. 230, 408-415.
4. Bickel, P. E., Freeman, M., 1992. Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J. Clin. Invest. 90, 1450-1457.
5. Brett, J., Schmidt, A.M., Yan, S.D., et al., 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143, 1699-1712.
6. Brown, M.S., Goldstein, J.L., 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223-261.
7. Doi, T., Vlassara, H., Kirstein, M., et al., 1992. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 89, 2873-2877.
8. Elomaa, O., Kangas, M., Sahlberg, C., et al., 1995. Cloning of novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80, 603-609.
9. Endermann, G., Stanton, L.W., Madden, K.S., et al., 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268, 11 811-11 816.
10. Federoff, H.J., Lawrence, D., Brownlee, M., 1993. Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth. Diabetes 42, 509-513.
11. Freeman, M., Ekkel, Y., Rohrer, L., et al., 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 88, 4931-4935.
12. Goldstein, J.L., Ho, Y.K., Basu, S.K., Brown, M.S., 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76, 333-337.
13. Higashi, T., Sano, H., Saishoji, T., et al., 1997. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 46, 463-472.
14. r 80 000 from human epithelial cells and identification as proper substrates for protein kinase C. Biochem. J. 270, 583-589.
15. Hori, O., Brett, J., Slattery, T., et al., 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J. Biol. Chem. 270, 25 752-25 761.
16. Horiuchi, S., Takata, K., Maeda, H., Morino, Y., 1985. Scavenger function of sinusoidal liver cells: acetylated low-density lipoprotein is endocytosed via a route distinct from formaldehyde-treated serum albumin. J. Biol. Chem. 260, 53-56.
17. Horiuchi, S., Takata, K., Morino, Y., 1985. Characterization of a membrane associated receptor from rat sinusoidal liver cells that binds formaldehyde-treated serum albumin. J. Biol. Chem. 260, 475-481.
18. Horiuchi, S., Murakami, M., Takata, K., Morino, Y., 1986. Scavenger receptor for aldehyde-modified proteins. J. Biol. Chem. 261, 4962-4966.
19. Horiuchi, S., Araki, N., Morino, Y., 1991. Immunochemical approach to characterize advanced glycation end products of Maillard reaction; evidence for the presence of a common structure. J. Biol. Chem. 266, 7329-7332.
20. Kirstein, M., Aston, C., Hintz, R., Vlassara, H., 1992. Receptor-specific induction of insulin-like growth factor I (IGF-I) in human monocytes by advanced glycosylation endproduct-modified proteins. J. Clin. Invest. 90, 439-446.
21. Kodama, T., Freeman, M., Rohrer, L., et al., 1990. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 343, 531-535.
22. Kume, S., Takeya, M., Mori, T., et al., 1995. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta using a novel specific monoclonal antibody. Am. J. Pathol. 147, 654-667.
23. Li, Y.M., Mitsuhashi, T., Wojciechowicz, D., et al., 1996. Molecular identity and cellullar distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl. Acad. Sci. USA 93, 11 047-11 052.
24. Ling, W., Lougheed, M., Suzuki, H., et al., 1997. Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene. J. Clin. Invest. 100, 244-252.
25. Maillard, L.C., 1912. Action des acides amines sur les sucres; formation des melanoidines par voie methodique. C.R. Acad. Sci. (Paris) 154, 66-68.
26. Makino, H., Shikata, K., Hironaka, K., et al., 1995. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int. 48, 517-526.
27. Makita, Z., Radoff, S., Rayfield, E.J., et al., 1991. Advanced glycosylation end products in patients with diabetic nephropathy. New Engl. J. Med. 325, 836-842.
28. Matsumoto, A., Naito, M., Itakura, H., et al., 1990. Human macrophage scavenger receptors, primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87, 9133-9137.
29. Mego, J.L., Bertini, F., McQueen, J.D., 1967. The use of formaldehyde-treated 131-I-albumin in the study of digestive vacuoles and some properties of these particles from mouse liver. J. Cell Biol. 32, 699-707.
30. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 92, 1243-1252.
31. ε-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J. Invest. Dermatol. 108, 797-802.
32. Naito, M., Suzuki, H., Mori, T., et al., 1992. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am. J. Pathol. 141, 591-599.
33. Nakamura, Y., Horii, Y., Nishino, T., et al., 1993. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143, 1649-1656.
34. Nakayama, H., Mitsuhashi, T., Kuwajima, S., et al., 1993. Immunochemical detection of advanced glycation end products in lens crystallines from streptozotocin induced diabetes rat. Diabetes 42, 345-350.
35. Neeper, M., Schmidt, A.M., Brett, J., et al., 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14 998-15 004.
36. Parkkinen, J., Raulo, E., Merenmies, J., et al., 1993. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem. 268, 19726-19738.
37. Radoff, S., Cerami, A., Vlassara, H., 1990. Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7. Diabetes 39, 1510-1518.
38. Ramprasad, M.P., Fischer, W., Witztum, J.L., et al., 1995. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA 92, 9580-9584.
39. Sano, H., Horiuchi, S., Higashi, T., et al., 1997. Experiments with the macrophage scavenger receptor (MSR)-deficient macrophages revealed a major role of MSR in endocytic uptake of advanced glycation endproducts. Circulation (Suppl.) 96, I-663.
40. Sano, H., Higashi, T., Matsumoto, K., et al., 1998. Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products. J. Biol. Chem. 273, 8630-8637.
41. Sawamura, T., Kume, N., Aoyama, T., et al., 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386, 73-77.
42. Schmidt, A.M., Vianna, M., Gerlach, M., et al., 1992. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997.
43. Schmidt, A.M., Hori, O., Chen, J.X., et al., 1995. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96, 1395-1403.
44. Silberstein, S., Kelleher, D.J., Gilmore, R., 1992. The 48-kDa subunit of the mammalian oligosaccharyl-transferase complex is homologous to the essential yeast protein WBP1. J. Biol. Chem. 267, 23658-23663.
45. Skolnik, E.Y., Yang, Z., Makita, Z., et al., 1991. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathy. J. Exp. Med. 174, 931-939.
46. Smedsrød, B., Melkko, J., Araki, N., et al., 1997. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem. J. 322, 567-573.
47. Stanton, L.W., White, R.T., Bryant, C.M., et al., 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267, 22446-22451.
48. Suzuki, H., Kurihara, Y., Takeya, M., et al., 1997. A role for macrophage scavenger receptor in atherosclerosis and susceptibility to infection. Nature 386, 292-296.
49. Takata, K., Horiuchi, S., Araki, N., et al., 1988. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins. J. Biol. Chem. 263, 14819-14825.
50. Vlassara, H., Brownlee, M., Cerami, A., 1985. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc. Natl. Acad. Sci. USA 82, 5588-5592.
51. Vlassara, H., Brownlee, M., Cerami, A., 1986. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J. Exp. Med. 164, 1301-1309.
52. Vlassara, H., Brownlee, M., Manogue, R.K., Cerami, A., 1992. Cachectin/ TNF and IL-1 induced by glucose modified proteins. Science 240, 156-157.
53. Vlassara, H., Bucala, R., Striker, L., 1994. Biology of Disease; Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70, 138-151.
54. Vlassara, H., Li, Y.M., Imani, F., et al., 1995. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol. Med. 1, 634-646.
55. Yagihashi, S., Kamijo, M., Baba, M., et al., 1992. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41, 47-52.
56. Yamagishi, S., Yonekura, H., Yamamoto, Y., et al., 1997. Advanced glycation end products driven angiogenesis in vivo. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factors. J. Biol. Chem. 272, 8723-8730.
57. Yan, S.D., Chen, X., Fu, J., et al., 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
58. Yang, Z., Makita, Z., Horii, Y., et al., 1991. Two novel rat liver membrane proteins that bind advanced glycation end products: relationship to macrophage receptor for glucose-modified proteins. J. Exp. Med. 174, 515-524.